The Southern Medical Journal (SMJ) is the official, peer-reviewed journal of the Southern Medical Association. It has a multidisciplinary and inter-professional focus that covers a broad range of topics relevant to physicians and other healthcare specialists.

SMJ // Article

Review Article

The 5 Ps of Acute Ischemic Stroke Treatment: Parenchyma, Pipes, Perfusion, Penumbra, and Prevention of Complications

Authors: Robert A. Felberg, MD, Andrew M. Naidech, MD

Abstract

Stroke is a treatable disease. Despite the therapeutic nihilism of the past, the advent of thrombolysis has changed the way stroke is approached. Acute ischemic stroke is a challenging and heterogeneous disease. Treatment needs to be based on an understanding of the underlying pathophysiology of ischemia. Interventions are designed to improve neuronal salvage and outcome. The underlying tenets of stroke therapy focus on the brain parenchyma, arterial flow (pipes), perfusion, the ischemic milieu or penumbra, and prevention of complications. This article focuses on the practical issues of ischemic stroke care, with a brief review of supporting literature.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

  1. Rowley HA. The four Ps of acute stroke imaging: Parenchyma, pipes, perfusion, and penumbra. AJNR Am J Neuroradiol 2001; 22: 599–601(editorial).
  2. Felberg RA, Grotta JC, Shirzadi AL, Strong R, Narayana P, Hill-Felberg SJ, et al. Cell death in experimental intracerebral hemorrhage: the “black hole” model of hemorrhagic damage. Ann Neurol 2002; 51: 517–524. 3. Felberg RA, Burgin WS, Grotta JC. Neuroprotection and the ischemic cascade. CNS Spectrs 2000; 5 ( 3): 52–58. 4. Schellinger P, Jansen O, Fiebach J, Hacke W, Sartor K. A standardized MRI stroke protocol: Comparison with CT in hyperacute intracerebral hemorrhage. Stroke 1999; 30: 765–768.
  3. 5. Schriger DL, Kalafut M, Starkman S, Krueger M, Saver JL. Cranial computed tomography interpretation in acute stroke: Physician accuracy in determining eligibility for thrombolytic therapy. JAMA 1998; 279: 1293–1297.
  4. 6. Grotta JC, Chiu D, Lu M, Patel S, Levine SR, Tilley BC, et al. Agreement and variability in the interpretation of early CT changes in stroke patients qualifying for intravenous rtPA therapy. Stroke 1999; 30: 1528–1533.
  5. 7. Hacke W, Schwab S, Horn M, Spranger M, De Georgia M, von Kummer R. “Malignant” middle cerebral artery territory infarction: Clinical course and prognostic signs. Arch Neurol 1996; 53: 309–315.
  6. 8. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333: 1581–1587.
  7. 9. Clark WM, Albers GW, Madden KP, Hamilton S. The rtPA (alteplase) 0- to 6-hour acute stroke trial, part A (A0276g): Results of a double-blind, placebo-controlled, multicenter study—Thrombolytic Therapy in Acute Ischemic Stroke Study Investigators. Stroke 2000; 31: 811–816.
  8. 10. del Zoppo GJ, Higashida RT, Furlan AJ, Pessin MS, Rowley HA, Gent M. PROACT: A Phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke—PROACT Investigators: Prolyse in Acute Cerebral Thromboembolism. Stroke 1998; 29: 4–11.
  9. 11. Khasani S, Ramee SR, Felberg RA. Therapy of postoperative stroke: Report of intra-arterial thrombolysis of a hyperacute embolic stroke 5 days following CABG. Catheter Cardiovasc Interv 2001; 54: 339–341.
  10. 12. Ueda T, Sakaki S, Nochide I, Kumon Y, Kohno K, Ohta S. Angioplasty after intra-arterial thrombolysis for acute occlusion of intracranial arteries. Stroke 1998; 29: 2568–2574.
  11. 13. Dion JE, Gates PC, Fox AJ, Barnett HJ, Blom RJ. Clinical events following neuroangiography: A prospective study. Stroke 1987; 18: 997–1004.
  12. 14. Earnest F IV, Forbes G, Sandok BA, Piepgras DG, Faust RJ, Ilstrup DM, et al. Complications of cerebral angiography: Prospective assessment of risk. AJR Am J Roentgenol 1984; 142: 247–253.
  13. 15. Connors JJ III, Wojak JC. Percutaneous transluminal angioplasty for intracranial atherosclerotic lesions: Evolution of technique and short-term results. J Neurosurg 1999; 91: 415–423.
  14. 16. Kellogg JX, Nesbit GM, Clark WM, Barnwell SL. The role of angioplasty in the treatment of cerebrovascular disease. Neurosurgery 1998; 43: 549–556.
  15. 17. Callahan AS III, Berger BL. Balloon angioplasty of intracranial arteries for stroke prevention. J Neuroimaging 1997; 7: 232–235.
  16. 18. Senior K. Taking the bite out of snake venoms. Lancet 1999; 353: 1946.
  17. 19. Chinese Acute Stroke Trial (CAST) Collaborative Group. Randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. Lancet 1997; 349: 1641–1649.
  18. 20. Bittl JA, Ahmed WH. Relation between abrupt vessel closure and the anticoagulant response to heparin or bivalirudin during coronary angioplasty. Am J Cardiol 1998; 82( Suppl 8B): 50P–56P.
  19. 21. Ackerman RH, Correia JA, Alpert NM, Baron JC, Gouliamos A, Grotta JC, et al. Positron imaging in ischemic stroke disease using compounds labeled with oxygen 15: Initial results of clinicophysiologic correlations. Arch Neurol 1981; 38: 537–543.
  20. 22. Fischberg GM, Lozano E, Rajamani K, Ameriso S, Fisher MJ. Stroke precipitated by moderate blood pressure reduction. J Emerg Med 2000; 19: 339–346.
  21. 23. Wojner AW, El-Mitwalli A, Alexandrov AV. Effect of head positioning on intracranial blood flow velocities in acute ischemic stroke: A pilot study. Crit Care Nurs Q 2002; 24: 57–66.
  22. 24. The Hemodilution in Stroke Study Group. Hypervolemic hemodilution treatment of acute stroke: Results of a randomized multicenter trial using pentastarch. Stroke 1989; 20: 317–323.
  23. 25. Rordorf G, Koroshetz WJ, Ezzeddine MA, Segal AZ, Buonanno FS. A pilot study of drug-induced hypertension for treatment of acute stroke. Neurology 2001; 56: 1210–1213.
  24. 26. Lewandowski C, Barsan W. Treatment of acute ischemic stroke. Ann Emerg Med 2001; 37: 202–216.
  25. 27. McCowen KC, Malhotra A, Bistrian BR. Stress-induced hyperglycemia. Crit Care Clin 2001; 17: 107–124.
  26. 28. Bruno A, Biller J, Adams HP Jr, Clarke WR, Woolson RF, Williams LS, et al. Acute blood glucose level and outcome from ischemic stroke: Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators. Neurology 1999; 52: 280–284.
  27. 29. Demchuk AM, Tanne D, Hill MD, Kasner SE, Hanson S, Grond M, et al. Predictors of good outcome after intravenous tPA for acute ischemic stroke. Neurology 2001; 57: 474–480.
  28. 30. Azzimondi G, Bassein L, Nonino F, Fiorani L, Vignatelli L, Re G, et al. Fever in acute stroke worsens prognosis: A prospective study. Stroke 1995; 26: 2040–2043.
  29. 31. Hajat C, Hajat S, Sharma P. Effects of poststroke pyrexia on stroke outcome: A meta-analysis of studies in patients. Stroke 2000; 31: 410–414.
  30. 32. Ginsberg MD, Busto R. Combating hyperthermia in acute stroke: A significant clinical concern. Stroke 1998; 29: 529–534.
  31. 33. Mayer S, Commichau C, Scarmeas N, Presciutti M, Bates J, Copeland D. Clinical trial of an air-circulating cooling blanket for fever control in critically ill neurologic patients. Neurology 2001; 56: 292–298.
  32. 34. The RANTTAS Investigators. A randomized trial of tirilazad mesylate in patients with acute stroke (RANTTAS). Stroke 1996; 27: 1453–1458.
  33. 35. Wahlgren NG, Ranasinha KW, Rosolacci T, Franke CL, van Erven PM, Ashwood T, et al. Clomethiazole acute stroke study (CLASS): Results of a randomized, controlled trial of clomethiazole versus placebo in 1360 acute stroke patients. Stroke 1999; 30: 21–28.
  34. 36. Diener HC, Cortens M, Ford G, Grotta J, Hacke W, Kaste M, et al. Lubeluzole in acute ischemic stroke treatment: A double-blind study with an 8-hour inclusion window comparing a 10-mg daily dose of lubeluzole with placebo. Stroke 2000; 31: 2543–2551.
  35. 37. Anderson DC, Bottini AG, Jagiella WM, Westphal B, Ford S, Rockswold GL, et al. A pilot study of hyperbaric oxygen in the treatment of human stroke. Stroke 1991; 22: 1137–1142.
  36. 38. Treib J, Grauer MT, Woessner R, Morgenthaler M. Treatment of stroke on an intensive stroke unit: A novel concept. Intensive Care Med 2000; 26: 1598–1611.
  37. 39. Stroke Unit Trialists Collaboration. How do stroke units improve patient outcomes? A collaborative systematic review of the randomized trials. Stroke 1997; 28: 2139–2144.
  38. 40. Stroke Unit Trialists’ Collaboration. Collaborative systematic review of the randomised trials of organised inpatient (stroke unit) care after stroke. BMJ 1997; 314: 1151–1159.